NCT01411319View on ClinicalTrials.gov

MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 27, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

March 2, 2020

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
RADIATION

Lattice Extreme Ablative Dose Radiation Therapy

12 - 14 Gy dose pipes in 1 fraction to the multiparametric MRI defined gross tumor volumes (GTV) on Day 1.

RADIATION

Standard IMRT

76 Gy in 38 fractions (2 Gy daily) of Standard Intensity-modulated radiation therapy (IMRT) starting on Day 2 for 7.5 weeks.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Miami

OTHER

NCT01411319 - MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer | Biotech Hunter | Biotech Hunter